InfuSystem Holdings Inc. (INFU) reported that its fourth-quarter net income was $0.2 million, equal to $0.01 per share, compared to a net loss of $0.8 million or $0.04 per share, in the prior year period.
Revenues in the fourth quarter were $16.2 million, up 16% from $14.0 million in the fourth quarter of 2011.
For the full year ended December 31, 2012, the company's net loss was $1.5 million, or $0.07 per share, versus a net loss of $45.4 million, or $2.16 per share, in 2011. The prior- year period included a $67.6 million asset impairment charge.
Total revenues for the year were $58.8 million, an 8% improvement from $54.6 million in 2011. The increase in revenues was primarily related to the addition of larger customers, increased penetration into existing customer accounts, and the resolution of the oncology drug shortage from 2011.
For comments and feedback: editorial@rttnews.com